News and Events

The UK aid Fleming Fund Country Grant to Indonesia (FFCGI) enters its second phase of support to Indonesia, providing technical assistance to the country’s government in addressing the threat of antimicrobial resistance (AMR) - with a new investment of GBP 5.8 million/IDR 120 billion from 2024-2026.

Phase II of the Fleming Fund in Malawi means a further £3m of investment in laboratories, disease surveillance systems, and the workforce in human, animal, and environmental sectors.

The fourth annual Fleming Fund Fellows Symposium showcased and explored the Fellow contributions to AMR surveillance and global health.

On International Women's Day, we celebrate the Fleming Fund Policy Fellows Dr Romona Ndanyi and Dr Evelyn Wesangula, supported by the University of Edinburgh, who have produced a powerful documentary on the real-life impact of AMR, ‘The Silent Pandemic'.

Since 1999, ongoing national surveillance in Nepal shows antimicrobial resistance (AMR) is rising. However, data analysis on its drivers, such as irrational AMU (antimicrobial use), do not follow the same trend.

Last week, Fleming Fund regional grantee the African Society of Laboratory Medicine (ASLM) held its sixth biennial conference, returning to Cape Town, South Africa, from 12-15 December.

A plaque on the side of the Saint Mary’s Hospital in Paddington, London, UK, commemorates the discovery of penicillin, the first antibiotic, in 1928. Fungal spores, blown by the wind, landed on Sir Alexander Fleming's Petri dishes killing the bacteria he was growing leading to a revolution in medicine.

To mark One Health Day, we revisit the holistic concept spanning human, animal, and environmental health, which is one of the Fleming Fund’s guiding principles.

Supported by the Fleming Fund, the African Society for Laboratory Medicine (ASLM) and its partners are enhancing AMR data surveillance training to empower countries across Africa and Asia in tackling drug resistance.

Up to £210 million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance and reduce the threat posed to the UK.